A recent study found that more than half of HT patients (54%) had signs of DED, and notably the tear interleukin-6 (IL-6) level was significantly elevated in the HT-DED subgroup (with a concurrent decrease in the anti-inflammatory cytokine IL-10) [4]. The gene discussed is IL10; the disease is hematocrit.